 | Articles: Drug/Product Approvals |
Allergan Submits Oral Tazarotene for FDA Approval to Treat Psoriasis; Company Announces Its Partnership Plans for the Tazarotene Molecule
Allergan, 11/26/03
FDA OKs Mylan's form of Duragesic pain patch
Corporate News Releases, 11/25/03
Lilly ICOS Announces FDA Approval of Cialis (tadalafil), A New Oral Treatment for Erectile DysfunctionÂ
Lilly, 11/24/03
FDA Clears DePuy Orthopaedics' Surgical Implant For Expanded Use on Rotator Cuff Injuries
Johnson & Johnson, 11/21/03
GlaxoSmithKline receives US approval of Advair Diskus 250/50 for the treatment of COPD associated with chronic bronchitis
GlaxoSmithKline, 11/19/03
Pfizer's Vfend Receives FDA Approval for Treatment of Esophageal Candidiasis
Pfizer, 11/18/03
Happy Thanksgiving, Genentech
Forbes, 10/29/03
FDA Approves Raptiva (efalizumab) for Chronic Moderate-to-Severe Plaque Psoriasis
Genentech, 10/28/03
LEVAQUIN Receives FDA Approval For Five-Day Treatment Of Community Acquired Pneumonia
Johnson & Johnson, 10/27/03
FDA Approves Enbrel For Once-Weekly Dosing
Amgen, 10/21/03
|
 Receive daily email updates on Drug/Product Approvals
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
188 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
